Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection
- PMID: 30101552
- PMCID: PMC7169080
- DOI: 10.1002/rmv.1995
Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection
Abstract
Acute respiratory tract infections are a major cause of morbidity and mortality and represent a significant burden on the health care system. Laboratory testing is required to definitively distinguish infecting influenza virus from other pathogens, resulting in prolonged emergency department (ED) visits and unnecessary antibiotic use. Recently available rapid point-of-care tests (POCT) may allow for appropriate use of antiviral and antibiotic treatments and decrease patient lengths of stay. We undertook a systematic review to assess the effect of POCT for influenza on three outcomes: (1) antiviral prescription, (2) antibiotic prescription, and (3) patient length of stay in the ED. The databases Medline and Embase were searched using MeSH terms and keywords for influenza, POCT, antivirals, antibiotics, and length of stay. Amongst 245 studies screened, 30 were included. The majority of papers reporting on antiviral prescription found that a positive POCT result significantly increased use of antivirals for influenza compared with negative POCT results and standard supportive care. A positive POCT result also led to decreased antibiotic use. The results of studies assessing the effect of POCT on ED length of stay were not definitive. The studies assessed in this systematic review support the use of POCT for diagnosis of influenza in patients suffering an acute respiratory infection. Diagnosis using POCT may lead to more appropriate prescription of treatments for infectious agents. Further studies are needed to assess the effect of POCT on the length of stay in ED.
Keywords: influenza; point of care; systematic review.
© 2018 John Wiley & Sons, Ltd.
Conflict of interest statement
The authors have no competing interest.
Figures
Similar articles
-
Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.Cochrane Database Syst Rev. 2022 Oct 17;10(10):CD010130. doi: 10.1002/14651858.CD010130.pub3. Cochrane Database Syst Rev. 2022. PMID: 36250577 Free PMC article.
-
The Impact of Point-of-Care Testing for Influenza on Antimicrobial Stewardship in UK Primary Care: Nested Cohort Study.JMIR Public Health Surveill. 2025 Jul 15;11:e72322. doi: 10.2196/72322. JMIR Public Health Surveill. 2025. PMID: 40663790 Free PMC article.
-
Delayed antibiotics for symptoms and complications of respiratory infections.Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004417. doi: 10.1002/14651858.CD004417.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004417. doi: 10.1002/14651858.CD004417.pub3. PMID: 15495108 Updated.
-
Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings.Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD012476. doi: 10.1002/14651858.CD012476.pub2. Cochrane Database Syst Rev. 2022. PMID: 36004796 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Viral co-infections are associated with increased rates of hospitalization in those with influenza.Influenza Other Respir Viruses. 2022 Jul;16(4):780-788. doi: 10.1111/irv.12967. Epub 2022 Mar 18. Influenza Other Respir Viruses. 2022. PMID: 35302283 Free PMC article.
-
Low Uptake of Rapid Diagnostic Tests for Respiratory Tract Infections in an Urban Safety Net Hospital.Open Forum Infect Dis. 2020 Mar 3;7(3):ofaa057. doi: 10.1093/ofid/ofaa057. eCollection 2020 Mar. Open Forum Infect Dis. 2020. PMID: 32166096 Free PMC article.
-
Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review.PLoS One. 2024 Jun 13;19(6):e0303560. doi: 10.1371/journal.pone.0303560. eCollection 2024. PLoS One. 2024. PMID: 38870136 Free PMC article.
-
Recent progress in chemical approaches for the development of novel neuraminidase inhibitors.RSC Adv. 2021 Jan 6;11(3):1804-1840. doi: 10.1039/d0ra07283d. eCollection 2021 Jan 4. RSC Adv. 2021. PMID: 35424082 Free PMC article. Review.
-
Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study.Antimicrob Resist Infect Control. 2019 Jul 16;8:120. doi: 10.1186/s13756-019-0575-6. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31346461 Free PMC article.
References
-
- World Health Organisation . Top 10 causes of death fact sheet No. 310.2018; http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed Feb 10, 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical